Metraipolis › archive › dc_7802b746177d

Orlistat: a comprehensive review of a lipase inhibitor from obesity management to emerging oncological applications — Europe PMC PMID:42812879

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42812879
DOI
10.3389/fphar.2026.1944242
License (as archived)
solo-consultazione
Archived
2026-10-09T22:52:34.599Z
SHA-256 of the archived text
1edb9e93cf9198e78463d4a2622d0aa8b3c9135276fb09f60112938f8165ef4f
Stable URL of this page
https://metraipolis.com/documento/dc_7802b746177d

How to cite

Orlistat: a comprehensive review of a lipase inhibitor from obesity management to emerging oncological applications — Europe PMC PMID:42812879 — Europe PMC (en), https://europepmc.org/article/MED/42812879 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7802b746177d (Metraipolis archive dc_7802b746177d, sha256 1edb9e93cf9198e78463d4a2622d0aa8b3c9135276fb09f60112938f8165ef4f)
BibTeX
@misc{dc7802b746177d,
  title = {Orlistat: a comprehensive review of a lipase inhibitor from obesity management to emerging oncological applications — Europe PMC PMID:42812879},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42812879},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7802b746177d; sha256 1edb9e93cf9198e78463d4a2622d0aa8b3c9135276fb09f60112938f8165ef4f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42812879. Agents can read the archived copy with the MCP tool read_document.